Most New Drugs in South Korea See Prices Cut After Listing, Study Finds
A longitudinal analysis of South Korea's National Health Insurance data found that 75.5 percent of 212 newly listed drugs underwent ...
A longitudinal analysis of South Korea's National Health Insurance data found that 75.5 percent of 212 newly listed drugs underwent ...
A review of nine European countries finds that only six of 22 licensed ATMPs were assessed by all national HTA ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.